101 – 110 of 161
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.
(
- Contribution to journal › Article
-
Mark
St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial
(
- Contribution to journal › Article
-
Mark
Variants at the 9p21 locus and melanoma risk
(
- Contribution to journal › Article
-
Mark
The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cells
(
- Contribution to journal › Article
-
Mark
Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer
(
- Contribution to journal › Article
-
Mark
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR
(
- Contribution to journal › Article
-
Mark
NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients
(
- Contribution to journal › Article
-
Mark
Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3
(
- Contribution to journal › Article
-
Mark
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
(
- Contribution to journal › Article